Incidental surgical findings of a phase I trial of weekly gemcitabine and concurrent radiotherapy in patients with unresectable non-small cell lung cancer-Reference-Cited by-同舟云学术

Incidental surgical findings of a phase I trial of weekly gemcitabine and concurrent radiotherapy in patients with unresectable non-small cell lung cancer

Published:2002-08 Issue:2 Volume:37 Page:207-212
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Cesario Alfredo,Margaritora Stefano,Trodella Lucio,Valente Salvatore,Corbo Giuseppe Maria,Macis Giuseppe,Galetta Domenico,d'Angelillo Rolando Maria,Porziella Venanzio,Ramella Sara,Mangiacotti Maria Grazia,Granone Pierluigi

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference38 articles.

1. The role of surgery in N2 lung cancer;Martini;Surg. Clin. N. Am.,1987

2. Revisions in the International System for staging lung cancer;Mountain;Chest,1997

3. The importance of surgery to NSCLC with mediastinal lymph-node metastasis;Naruke;Ann. Thorac. Surg.,1988

4. Phase I/II study of treatment of locally advanced (T3/T4) non-oat cell lung cancer with concomitant boost radiotherapy by the Radiation Therapy Oncology Group (RTOG 83-12): long-term results;Graham;Int. J. Radiat. Oncol. Biol. Phys.,1995

5. Chemotherapy versus supportive care in advanced NSCLC: results of meta-analysis of the literature;Marino;Chest,1994

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ACR Appropriateness Criteria® Induction and Adjuvant Therapy for N2 Non–small-cell Lung Cancer;American Journal of Clinical Oncology;2015-04

2. A phase I study of gemcitabine plus palliative radiation therapy for advanced lung cancer;Cancer Chemotherapy and Pharmacology;2008-02-28

3. INDUCTION AND ADJUVANT THERAPY FOR OPERABLE NON–SMALL CELL LUNG CANCER;Pearson's Thoracic and Esophageal Surgery;2008

4. Lessons to learn from EORTC study 08981: A feasibility study of induction chemoradiotherapy followed by surgical resection for stage IIIB non-small cell lung cancer;Lung Cancer;2007-01

5. The radiosensitising effect of difluorodeoxyuridine, a metabolite of gemcitabine, in vitro;Cancer Chemotherapy and Pharmacology;2005-12-06